ENGLEWOOD, Colo., Aug. 20, 2019 /PRNewswire/ -- In partnership with Cedar, a leading patient payment and engagement platform,

HOUSTON, Aug. 20, 2019 /PRNewswire/ -- Soliton, Inc., (NASDAQ:SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announced results of preclinical studies which reveal its RAP de

ST. LOUIS, Aug. 20, 2019 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today it will present at the Wells Fargo Securities 2019 Healthcare Conference, to be held September 4-5, at the Westin Copley Plaza in Boston. Centene will present on Wednesday, September 4

HOUSTON, Aug. 20, 2019 /PRNewswire/ -- Millar, Inc., medical device manufacturer and

AUSTIN, Texas, Aug. 20, 2019 /PRNewswire/ -- Today, IGNITE, an all-female, and veterinarian owned, company specializing in job role specific skills training for veterinary teams, and case-based training for veterinarians and veterinary students, announced that Phase II of their learning platform construction is nearing completion.

PLYMOUTH MEETING, Pa., Aug. 20, 2019 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) has begun publishing updated versions of cancer care guidelines adapted

MENLO PARK, Calif., Aug. 20, 2019 /PRNewswire/ -- Today Health2047 Inc. is launching Zing Health, a tech-enabled health plan for those who are underserved by existing insurance plans. Co-founded by Health2047 with ex

LOS ANGELES, Aug. 20, 2019 /PRNewswire/ -- Zynx Health™,  market leader in providing evidence- and experience-based clinical improvement solutions since 1996, announced today the release

HOUSTON, Aug. 20, 2019 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today announced approval by the Emory University Clinical Trial Review Committee (CTRC) to move forward with an

LUND, Sweden, Aug. 20, 2019 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) today announced that the company will host a Capital Markets Day in Stockholm on 9 October, 2019, for investors, analysts and media.Presentations will be ma